135 related articles for article (PubMed ID: 18727636)
1. Interictal brain 5-HT1A receptors binding in migraine without aura: a 18F-MPPF-PET study.
Lothe A; Merlet I; Demarquay G; Costes N; Ryvlin P; Mauguière F
Cephalalgia; 2008 Dec; 28(12):1282-91. PubMed ID: 18727636
[TBL] [Abstract][Full Text] [Related]
2. Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.
Lothe A; Boni C; Costes N; Gorwood P; Bouvard S; Le Bars D; Lavenne F; Ryvlin P
Neuroimage; 2009 Aug; 47(2):482-92. PubMed ID: 19409499
[TBL] [Abstract][Full Text] [Related]
3. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging.
Costes N; Merlet I; Ostrowsky K; Faillenot I; Lavenne F; Zimmer L; Ryvlin P; Le Bars D
J Nucl Med; 2005 Dec; 46(12):1980-9. PubMed ID: 16330560
[TBL] [Abstract][Full Text] [Related]
4. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
[TBL] [Abstract][Full Text] [Related]
5. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
Sibon I; Benkelfat C; Gravel P; Aznavour N; Costes N; Mzengeza S; Booij L; Baker G; Soucy JP; Zimmer L; Descarries L
Biol Psychiatry; 2008 Jun; 63(12):1135-40. PubMed ID: 18191817
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.
Lothe A; Boni C; Costes N; Bouvard S; Gorwood P; Lavenne F; Alvarez M; Ryvlin P
Behav Brain Funct; 2010 Jul; 6():37. PubMed ID: 20609217
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.
Lothe A; Didelot A; Hammers A; Costes N; Saoud M; Gilliam F; Ryvlin P
Brain; 2008 Oct; 131(Pt 10):2765-82. PubMed ID: 18765418
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study.
Merlet I; Ostrowsky K; Costes N; Ryvlin P; Isnard J; Faillenot I; Lavenne F; Dufournel D; Le Bars D; Mauguière F
Brain; 2004 Apr; 127(Pt 4):900-13. PubMed ID: 14985263
[TBL] [Abstract][Full Text] [Related]
9. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.
Truchot L; Costes N; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
Neuroimage; 2008 Apr; 40(3):1251-6. PubMed ID: 18313943
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.
Sullivan GM; Ogden RT; Oquendo MA; Kumar JS; Simpson N; Huang YY; Mann JJ; Parsey RV
Biol Psychiatry; 2009 Aug; 66(3):223-30. PubMed ID: 19278673
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
Frey BN; Rosa-Neto P; Lubarsky S; Diksic M
Neuroimage; 2008 Aug; 42(2):850-7. PubMed ID: 18583156
[TBL] [Abstract][Full Text] [Related]
12. Brainstem changes in 5-HT1A receptor availability during migraine attack.
Demarquay G; Lothe A; Royet JP; Costes N; Mick G; Mauguière F; Ryvlin P
Cephalalgia; 2011 Jan; 31(1):84-94. PubMed ID: 21036859
[TBL] [Abstract][Full Text] [Related]
13. Test-retest reproducibility of 18F-MPPF PET in healthy humans: a reliability study.
Costes N; Zimmer L; Reilhac A; Lavenne F; Ryvlin P; Le Bars D
J Nucl Med; 2007 Aug; 48(8):1279-88. PubMed ID: 17631552
[TBL] [Abstract][Full Text] [Related]
14. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
la Fougère C; Böning G; Bartmann H; Wängler B; Nowak S; Just T; Wagner E; Winter P; Rominger A; Förster S; Gildehaus FJ; Rosa-Neto P; Minuzzi L; Bartenstein P; Potschka H; Cumming P
Neuroimage; 2010 Jan; 49(2):1406-15. PubMed ID: 19796699
[TBL] [Abstract][Full Text] [Related]
15. Quantifying drug-related 5-HT1A receptor occupancy with.
Passchier J; van Waarde A; Pieterman RM; Willemsen AT; Vaalburg W
Psychopharmacology (Berl); 2001 May; 155(2):193-7. PubMed ID: 11401009
[TBL] [Abstract][Full Text] [Related]
16. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
Vidal B; Sebti J; Verdurand M; Fieux S; Billard T; Streichenberger N; Troakes C; Newman-Tancredi A; Zimmer L
Neuropharmacology; 2016 Oct; 109():88-95. PubMed ID: 27183968
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study With 11C-WAY-100635 and 18F-MPPF.
Kitamura S; Kimura Y; Takahata K; Moriguchi S; Kubota M; Shimada H; Endo H; Takado Y; Kawamura K; Zhang MR; Suhara T; Higuchi M
Int J Neuropsychopharmacol; 2023 Jul; 26(7):474-482. PubMed ID: 37279545
[TBL] [Abstract][Full Text] [Related]
18. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study.
Galusca B; Costes N; Zito NG; Peyron R; Bossu C; Lang F; Le Bars D; Estour B
Biol Psychiatry; 2008 Dec; 64(11):1009-13. PubMed ID: 18639866
[TBL] [Abstract][Full Text] [Related]
19. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.
Bhagwagar Z; Rabiner EA; Sargent PA; Grasby PM; Cowen PJ
Mol Psychiatry; 2004 Apr; 9(4):386-92. PubMed ID: 15042104
[TBL] [Abstract][Full Text] [Related]
20. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S
Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
